Cliff Asness's BIOA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 51,918 shares of BioAge Labs, Inc. (BIOA) worth $686,876, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in BIOA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 16,172 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's BioAge Labs (BIOA) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioAge Labs (BIOA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +16,172 | Add 45.24% | 51,918 | $13.23 |
| Q3 2025 | +4,194 | Add 13.29% | 35,746 | $5.88 |
| Q2 2025 | +31,552 | New Buy | 31,552 | $4.13 |
Cliff Asness's BioAge Labs Investment FAQs
Cliff Asness first purchased BioAge Labs, Inc. (BIOA) in Q2 2025, acquiring 31,552 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held BioAge Labs, Inc. (BIOA) for 3 quarters since Q2 2025.
Cliff Asness's largest addition to BioAge Labs, Inc. (BIOA) was in Q2 2025, adding 31,552 shares worth $130,310.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 51,918 shares of BioAge Labs, Inc. (BIOA), valued at approximately $686,876.
As of the Q4 2025 filing, BioAge Labs, Inc. (BIOA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in BioAge Labs, Inc. (BIOA) was 51,918 shares, as reported at the end of Q4 2025.